{"id":"W2007200101","doi":"10.1016/j.clim.2014.06.006","title":"Targeting the IL-17/IFN-γ axis as a potential new clinical therapy for type 1 diabetes","year":2014,"lang":"en","type":"review","venue":"Clinical Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":50,"is_retracted":false,"has_abstract":false,"ca_institutions":"Child and Family Research Institute; University of British Columbia","funders":"","keywords":"Ustekinumab; Medicine; Immunology; Type 1 diabetes; Psoriasis; Interleukin 23; Secretion; Monoclonal antibody; Disease; Type 2 diabetes; Blockade; Monoclonal; Diabetes mellitus; Interleukin 17; Antibody; Cytokine; Internal medicine; Endocrinology; Tumor necrosis factor alpha; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004855273,0.0007269107,0.001277757,0.001104213,0.0001777312,0.0007274931,0.0006484928,0.0007965739,0.00318192],"category_scores_gemma":[0.0003979391,0.0002201575,0.0003796664,0.0008847299,0.0003592229,0.0009165643,0.0005424496,0.002448636,0.001602632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000367596,"about_ca_system_score_gemma":0.0006731934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004892535,"about_ca_topic_score_gemma":0.001342698,"domain_scores_codex":[0.9998823,0.00001898169,0.0000150853,0.00001725852,0.00004902627,0.00001723074],"domain_scores_gemma":[0.9998146,0.00007362901,0.00003208473,0.000004943522,0.00005046255,0.00002445451],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001684582,0.0001100505,0.0001197103,0.006970217,0.00007527949,0.0001494408,0.00002100423,0.0002685943,0.002899238,0.002141094,0.03241343,0.9546635],"study_design_scores_gemma":[0.0001104791,0.0002157043,0.0007338526,0.002040277,0.0001814394,0.00113779,0.00004127994,0.0002019855,0.001019697,0.002302878,0.9919917,0.0000230143],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001468378,0.9982694,0.0002010267,0.0003479188,0.0003603765,0.000005175,0.00001410349,0.000009202483,0.0006459883],"genre_scores_gemma":[0.001115363,0.9971142,0.0002795454,0.0003522715,0.0003741266,0.000007512724,0.00003289705,0.000001893795,0.0007221361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00318192,"threshold_uncertainty_score":0.01064461,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1146624484401171,"score_gpt":0.4090297676395804,"score_spread":0.2943673191994634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}